Obama's budget good news for FDA

February 2011
Chain Drug Review;2/28/2011, Vol. 33 Issue 4, p1
Trade Publication
The article reports on the budget of the Food and Drug Administration (FDA) which was increased by U.S. President Barack Obama by 33 percent for fiscal 2012.


Related Articles

  • FDA Claims User Fees Necessary to Implement FSMA.  // Food Logistics;Apr2014, Issue 155, p10 

    The article reports on the user fees proposed by the U.S. Food and Drug Administration (FDA) in President Barack Obama's fiscal 2015 budget to help enforce the Food Safety Modernization Act (FSMA).

  • FDA budget relies heavily on user fee increase.  // Cardiovascular Devices & Drugs;Jun2009, Vol. 15 Issue 6, p20 

    The article reports on the proposed budget of U.S. President Barack Obama for the Food and Drug Administration (FDA) for the year 2010. It is noted that the budget of the agency is becoming heavily based on user fee increases. The increases will be used to fund two programs of the FDA,...

  • Health-Reform Controversies Pose New Challenges. Wechsler, Jill // BioPharm International;Apr2011, Vol. 24 Issue 4, p14 

    The article examines the implementation of the healthcare-reform program, proposed by the administration of U.S. President Barack Obama. It explores the uncertainties of the program as well as its impact on the biomedical innovation and drug development. It highlights the efforts of the Federal...

  • Washington letter.  // DCI;Oct94, Vol. 155 Issue 4, p8 

    Reports on the US Senate's agreement to a House request deleting user fees previously instituted by the Senate on its funding bill of the US Food & Drug Administration (FDA). House authority to originate revenue measures; Decision to come up with alternative funding.

  • FDA budget seems destined for cuts.  // Ophthalmology Times;7/10/95, Vol. 20 Issue 26, p3 

    Reports on the downsizing of US Food and Drug Administration's budget for 1996 by the House of Appropriations Committee. Limit of funds for overhead, publications and congressional affairs; Reallocations.

  • FDA budget cuts expected to delay drug approval rate.  // Chemical Market Reporter;04/07/97, Vol. 251 Issue 14, p14 

    Discloses the effect of a proposal by President Bill Clinton to cut back the budget of the United States Food and Drug Administration (FDA). Delay in drug approval rate; Total allocations for the FDA until 1997; Estimated fiscal 1998 funding for the agency; Improvements to the prescription drug...

  • Livable FDA budget advances. Dickinson, James G. // Medical Marketing & Media;Aug97, Vol. 32 Issue 8, p35 

    Reports on the US House Appropriations Committee's approval of the Food and Drug Administration's (FDA) fiscal year 1998 budget. Level funding for human drugs; FDA's total appropriation.

  • FDA spending plan mired at Office of Management & Budget.  // Medical Marketing & Media;Feb98, Vol. 33 Issue 2, p28 

    Reports that the US Food and Drug Administration (FDA) missed its new statutory December 22, 1997 deadline for filing an operating plan for fiscal year 1998 with the US Congress. Delay in the White House's Office of Management and Budget.

  • Washington letter.  // DCI;Aug94, Vol. 155 Issue 2, p8 

    Reports on the US Senate Appropriations Committee's decision to include user fees in the 1995 Food & Drug Administration (FDA) budget. Probability of House of Representatives' voting against the idea; Opposition to user fees by Cosmetic, Toiletry & Fragrance Association.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics